Testing Support Level, AstraZeneca Stock Drops 5.57% Today
Technical analysis of AstraZeneca stock on Juli 14, 2026: price 12,610.00 GBp, trend sideways, RSI 36.3, support 12,834.00, resistance 14,538.00.
Shares in AstraZeneca fell to 12,610.00 GBp on the LSE, down 5.57% from the previous close of 13,354.00, as shown in the chart and echoed by the broader slide over 5 days and 1 month. The move leaves the stock below both its short- and medium-term trend markers, which matters because it signals that recent selling has not just been a one-day event; it has been enough to pull price under the area where the shares had been trading more comfortably. In plain terms, the market is no longer rewarding the prior range, and the burden is now on buyers to prove they can absorb supply.
Trend & Price Action
The key structural point is that AstraZeneca is trading below SMA20 at 13,782.60 and below SMA50 at 13,705.00, with no fresh MA-cross to suggest a new trend regime. That combination usually means the market is drifting rather than accelerating, but not in a healthy way: the price is under the averages, while the averages themselves are not yet showing a decisive downward crossover that would confirm a full trend break. The stated trend is sideways, and the 0.34%/5 days SMA20 slope is a reminder that the longer-term structure has not yet rolled over sharply. Still, sideways on paper can mask weakness when the share price is sitting beneath the moving-average cluster, because it implies the stock is spending more time below consensus value than above it.
Support at 12,834.00 is the first level the chart is testing, and the stock is already trading below that support. That is important because broken support often turns into overhead resistance once sellers establish control. The next reference is resistance at 14,538.00, which sits well above the current price and would need a meaningful recovery to re-enter the prior trading band. The share is also positioned at roughly -13% of the 20-day range, which places it near the lower end of the recent corridor rather than in the middle. Against the 3-month high of 15,130.00 and 3-month low of 11,232.00, the stock is closer to the lower boundary, a sign that the market has already repriced some optimism out of the name.
Oscillators & Momentum
The momentum picture is weaker than the trend picture, and that distinction matters. RSI at 36.3 is technically neutral, but it is leaning toward the lower end of the scale, which means the stock is not yet deeply oversold even after the recent drop. That leaves room for further pressure if sentiment stays poor. The more telling signal is Stochastic %K at 19.4 versus %D at 41.9, which shows the faster line below the slower line and in oversold territory. As shown in the chart, that setup often reflects short-term exhaustion, but it is only a warning flag, not a reversal by itself.
The MACD is -1.992, with signal at 83.436 and histogram at -85.428. For non-specialists, MACD compares faster and slower price momentum; when it is negative and the histogram is deeply below zero, it means downside momentum is still dominating and has not yet meaningfully reversed. In other words, the stock can be oversold and still fall further if the momentum engine remains pointed down. The current reading does not support a clean recovery signal yet, even if the stochastic line is hinting that the move may be stretched.
Volatility & Volume
Volatility is elevated. ATR(14) at 599.71, or 4.8% of price, suggests the stock is capable of sizeable daily swings, which increases the chance that support and resistance can be tested quickly once a move starts. The Bollinger setup is also informative: upper band at 14,799.30, middle band at 13,782.60, and lower band at 12,765.90. The price is now below the lower band, with %B at -8%. That usually means the share has moved outside its normal volatility envelope, a condition that can sometimes precede a rebound, but more often simply confirms that selling has become extended.
The 14.8% Bollinger band width is described as normal rather than compressed, so this is not a classic squeeze setup where a breakout is being stored up. Instead, the chart suggests an active down move inside a still-functioning volatility range. Volume adds weight to that interpretation: 3,355,018 shares traded versus a 20-day average of 2,567,841, or about 1.3× normal. Higher turnover on a decline tends to indicate participation, not random noise. The fact that OBV is down reinforces that the volume flow has been net negative, meaning more shares have likely changed hands on down days than on up days.
Key Levels & Scenarios
12,834.00 is the nearest support reference, and the stock is already beneath it, so the market is effectively asking whether the next layer of demand can appear before the chart damages further. If the share stabilises here, the first technical task would be to reclaim the 12,765.90 lower Bollinger band and then move back toward the 13,782.60 middle band, where the short-term trend would begin to look less fragile. If it fails to hold the current area, the chart leaves room for a test of the lower end of the recent range, with the 11,232.00 3-month low acting as the next major reference point. On the upside, 14,538.00 resistance remains the level that would need to be recovered before the price structure could be described as repaired.
Technical Verdict: HOLD (wait & see)
HOLD (wait & see) because the stock is trading below SMA20 and SMA50, MACD remains negative with a deeply adverse histogram, and OBV is falling, which together show that downside momentum still has the upper hand. The only offset is that Stochastic is oversold and the price is already below the lower Bollinger band, which can sometimes precede a relief bounce rather than a fresh leg down. This verdict is invalidated if price breaks below 11,232.00.
For readers outside the market, that means the chart is weak, but not yet weak enough to confirm a new direction with confidence.
Volume last traded at 3,355,018 shares.
Summary Data AstraZeneca
| Last price | 12,610.00 GBp |
| Change 1 day / 5 days / 1 month | -5.57% / -12.77% / -6.33% |
| Trend / MA-cross | sideways / none |
| SMA20 / SMA50 | 13,782.60 / 13,705.00 |
| RSI (14) / Stochastic %K | 36.3 / 19.4 |
| Bollinger %B / ATR | -8% / 599.71 |
| Support / Resistance 20 days | 12,834.00 / 14,538.00 |
| Data as of | 10 Juli 2026 14:00 WIB |
